MOTS-c — Research Overview

Research Overview

MOTS-c is studied in mitochondrial signaling, metabolic adaptation and exercise biology. The field includes cell and animal experiments, alongside human observations of naturally occurring peptide levels. Those evidence types answer different questions. [1][2][3]

What the Compound Is

A 16-amino-acid peptide encoded within a mitochondrial ribosomal-RNA region. Studies investigate its role as a signal connecting mitochondrial biology with cellular responses. [1][3]

Regulatory or Investigational Status

MOTS-c remains an investigational research material, not an FDA-approved medicine. FDA identifies important gaps in human exposure and safety information for administered MOTS-c drug products. [4]

Mechanisms or Pathways Under Investigation

Experimental studies have explored folate-related metabolism, AMPK signaling and stress-dependent movement into the nucleus. These pathways offer hypotheses about cellular adaptation; they do not establish human performance or longevity outcomes. [1][3]

Major Research Context

Mouse studies evaluate metabolic measures and physical capacity. Human exercise observations concern endogenous MOTS-c, and should not be described as trials demonstrating benefit from administering the catalog peptide. [1][2]

Published Research Highlights

Cell and animal research · Metabolic regulation

Lee and colleagues characterized MOTS-c and reported effects on metabolic homeostasis in experimental systems. [1]

Animal experiments and human observations · Exercise

Reynolds and colleagues studied physical performance in mice and changes associated with exercise in humans. The human observations are not evidence of an injected intervention. [2]

Mechanistic research · Nuclear signaling

Kim and colleagues reported stress-associated nuclear translocation and gene-expression effects in cell models. [3]

Evidence Level and Research Limitations

Species differences, endogenous measurements and experimental delivery methods constrain translation. Observing a peptide during exercise does not show that administering it reproduces exercise adaptations. Long-term human effectiveness and safety remain unresolved. [1][2][3][4]

Selected Scientific References

Lee et al. MOTS-c promotes metabolic homeostasis in experimental models. Cell Metabolism, 2015. ↗Cell and animal study
Reynolds et al. MOTS-c, exercise and age-dependent physical decline. Nature Communications, 2021. ↗Animal experiments and human observations
Kim et al. MOTS-c translocates to the nucleus during metabolic stress. Cell Metabolism, 2018. ↗Mechanistic cell study
FDA. Selected peptide safety considerations, including MOTS-c. ↗Official regulatory material

Educational and Research Disclaimer

This page is for educational and scientific-reference purposes. It does not provide medical advice, diagnosis, treatment recommendations, dosing guidance or instructions for human use. References concern the specific materials and conditions studied; they are not evidence that an AUVYRON product has been evaluated in those studies. Product presentations are catalog identifiers, not use instructions.

FOR RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY USE.